ZHAI Yaling,LONG Xiaoqing,GAO Jingge, et al. Functional Difference Exploration of Circulating Immune Complex between Patients with IgA Nephropathy Only and Both with Diabetes Mellitus [J]. Chinese General Practice, 2020, 23(17): 2115-2119. DOI: 10.12114/j.issn.1007-9572.2020.00.154.
翟亚玲,龙晓青,高静歌等. 单纯IgA肾病与IgA肾病合并糖尿病患者循环免疫复合物的功能差异性探索研究[J]. 中国全科医学, 2020, 23(17): 2115-2119. DOI: 10.12114/j.issn.1007-9572.2020.00.154.
[1]BERGER J,LEVY M.Epidemiology of idiopathic IgA nephropathy[J].Semin Nephrol,1987,7(4):277-279.
[2]D'AMICO G.The commonest glomerulonephritis in the world:IgA nephropathy[J].Q J Med,1987,64(245):709-727.
[3]HERLITZ L C,BOMBACK A S,STOKES M B,et al.IgA nephropathy with minimal change disease[J].Clin J Am Soc Nephrol,2014,9(6):1033-1039.DOI:10.2215/cjn.11951113.
[4]ROBERTS I S D.Pathology of IgA nephropathy[J].Nat Rev Nephrol,2014,10(8):445-454.DOI:10.1038/nrneph.2014.92.
[5]NOVAK J,JULIAN B A,MESTECKY J,et al.Glycosylation of IgA1 and pathogenesis of IgA nephropathy[J].Semin Immunopathol,2012,34(3):365-382.DOI:10.1007/s00281-012-0306-z.
[6]CEDERHOLM B,WIESLANDER J,BYGREN P,et al.Circulating complexes containing IgA and fibronectin in patients with primary IgA nephropathy[J].Proc Natl Acad Sci USA,1988,85(13):4865-4868.DOI:10.1073/pnas.85.13.4865.
[7]VUONG M T,HAHN-ZORIC M,LUNDBERG S,et al.Association of soluble CD89 levels with disease progression but not susceptibility in IgA nephropathy[J].Kidney Int,2010,78(12):1281-1287.DOI:10.1038/ki.2010.314.
[8]BERTHELOT L,PAPISTA C,MACIEL T T,et al.Transglutaminase is essential for IgA nephropathy development acting through IgA receptors[J].J Exp Med,2012,209(4):793-806.DOI:10.1084/jem.20112005.
[9]CHANG Y H,LEI C C,LIN K C,et al.Serum uric acid level as an indicator for CKD regression and progression in patients with type 2 diabetes mellitus-a 4.6-year cohort study[J].Diabetes Metab Res Rev,2016,32(6):557-564.DOI:10.1002/dmrr.2768.
[10]LIU X M,WANG Q,DONG Z Y,et al.Clinicopathological features of nondiabetic renal diseases from different age groups:an observational cross-sectional study[J].Chin Med J,2018,131(24):2953-2959.DOI:10.4103/0366-6999.247197.
[11]龙晓青,翟亚玲,王英姿,等.IgA肾病合并糖尿病患者的临床病理改变特点[J].中华肾脏病杂志,2018,34(12):887-892.DOI:10.3760/cma.j.issn.1001-7097.2018.12.002.http://d.old.wanfangdata.com.cn/Periodical/zhszb98201812002.